Clincosm LogoSign in Get a demo

Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at Strasbourg University Hospitals

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Completed
CT.gov ID
NCT04706260
Collaborator
(none)
600
Enrollment
1
Location
12
Actual Duration (Months)
50
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

A SARS-CoV-2 infection emerged in China in December 2019, the severity of which is linked to acute respiratory distress syndrome1. The rate of emergency visits in Bas-Rhin for suspected Covid-19 increased, compared to the French average, at the end of the 10th week of 2020.

Compared to the onset of symptoms, Chinese studies estimate the onset of dyspnea on the 7th day3 and admission to the emergency room between the 5th and the 9th day4. But this duration varies according to the epidemic period5, the geographical location6 and a later emergency admission is associated with an increase in mortality in the Chinese population7.

The need for oxygen, which is not noted in Chinese studies8, is a reflection of the onset of respiratory worsening and a major factor in hospitalization. There is no study on the changing profile of the French population to date its onset.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    600 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at the University Hospitals of Strasbourg : A Retrospective Observational Study
    Actual Study Start Date :
    Apr 14, 2020
    Actual Primary Completion Date :
    Apr 14, 2021
    Actual Study Completion Date :
    Apr 14, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Retrospective evaluation of the clinical evolution and becoming of adult patients infected with Covid-19 hospitalized at the University Hospitals of Strasbourg from the Emergency Structure [Files analysed retrospectily from March 06, 2020 to April 05, 2020 will be examined]]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Male or female aged 18 or over

    • Admitted to the NHC emergency room and hospitalized at the Strasbourg University Hospitals (HUS) between 06/03/2020 and 05/04/2020.

    • With SARS-CoV-2 RT-PCR on a positive nasopharyngeal sample taken at the SU.

    Exclusion Criteria:

    • Refusal to participate in the study

    • Return home from the SU

    • Transfer to another establishment

    • Patient under the protection of justice

    • Patient under guardianship, curatorship

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Adult Emergency Department - Strasbourg University Hospitals Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    • Study Director: Mathieu OBERLIN, MD, Adult Emergency Department - Strasbourg University Hospitals

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT04706260
    Other Study ID Numbers:
    • 7839
    First Posted:
    Jan 12, 2021
    Last Update Posted:
    Oct 7, 2021
    Last Verified:
    Jan 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    COVID-19
    COVID-19 Pandemic
    Sars-cov-2
    Emergency Department
    Additional relevant MeSH terms:
    COVID-19

    Study Results

    No Results Posted as of Oct 7, 2021